Surgical Neurology
Volume 71, Issue 2 , Pages 161-165 , February 2009

Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma

  • Hyun-Jong Hong, MD

      Affiliations

    • Department of Neurosurgery, Seoul Medical Center, Seoul 135-740, South Korea
    • ,
  • Young-Jin Kim, MD

      Affiliations

    • Department of Neurosurgery, Dankook University Hospital, Cheonan-si 330-715, South Korea
    • ,
  • Hyeong-Joong Yi, MD

      Affiliations

    • Department of Neurosurgery, Hanyang University Medical Center, Seoul 133-792, South Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 2 2290 8499; fax: +82 2 2281 0954.
    • ,
  • Yong Ko, MD

      Affiliations

    • Department of Neurosurgery, Hanyang University Medical Center, Seoul 133-792, South Korea
    • ,
  • Suck-Jun Oh, MD

      Affiliations

    • Department of Neurosurgery, Hanyang University Medical Center, Seoul 133-792, South Korea
    • ,
  • Jae-Min Kim, MD

      Affiliations

    • Department of Neurosurgery, Hanyang University Guri Hospital, Guri 471-701, South Korea

Received 21 October 2007 ,Accepted 5 January 2008.

References 

  1. Bikfalvi A, Sauzeau C, Moukadiri H, et al. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological efforts. J Cell Physiol. 1991;149:50–59
  2. El-Kadi H, Miele VJ, Kaufman HH. Prognosis of chronic subdural hematomas. Neurosurg Clin N Am. 2000;11:553–567
  3. Ferrara N. Vascular endothelial growth factor. Eur J Cancer. 1996;32A:2413–2422
  4. Fukuhara T, Gotoh M, Asari S, et al. The relationship between brain surface elastance and brain reexpansion after evacuation of chronic subdural hematoma. Surg Neurol. 1996;45:570–574
  5. Frati A, Salvati M, Mainiero F, et al. Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J Neurosurg. 2004;100:24–32
  6. Fujisawa H, Ito H, Kashiwagi S, et al. Kallikrein-kinin system in chronic subdural haematomas: its role in vascular permeability and regulation of fibrinolysis and coagulation. J Neurol Neurosurg Psychiatry. 1995;59:388–394
  7. Ito H, Saito K, Yamamoto S, et al. Tissue-type plasminogen activator in the chronic subdural hematoma. Surg Neurol. 1988;30:175–179
  8. Katano H, Kamiya K, Mase M, et al. Tissue plasminogen activator in chronic subdural hematoma as a predictor of recurrence. J Neurosurg. 2006;104:79–84
  9. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992;258:1798–1801
  10. Kwon TH, Park YK, Lim DJ, et al. Chronic subdural hematoma: evaluation of the clinical significance of postoperative drainage volume. J Neurosurg. 2000;93:796–799
  11. Maruo N, Morita I, Shirao M, et al. IL-6 increases endothelial permeability in vitro. Endocrinology. 1992;131:710–714
  12. Murakami H, Hirose Y, Sagoh M, et al. Why do chronic subdural hematomas continue to grow slowly and not coagulate? Role of thrombomodulin in the mechanism. J Neurosurg. 2002;96:877–884
  13. Nakaguchi H, Tanishima T, Yoshimasu N. Factors in the natural history of chronic subdural hematomas that influence their postoperative recurrence. J Neurosurg. 2001;95:256–262
  14. Nomura S, Kashiwagi S, Fujisawa H, et al. Characterization of local hyperfibrinolysis in chronic subdural hematomas by SDS-PAGE and immunoblot. J Neurosurg. 1994;81:910–913
  15. Oishi M, Toyama M, Tamatani S, et al. Clinical factors of recurrent chronic subdural hematoma. Neurol Med Chir (Tokyo). 2001;41:382–386
  16. Shono T, Inamura T, Morioka T, et al. Vascular endothelial growth factor in chronic subdural hematomas. J Clin Neurosci. 2001;8:411–415
  17. Suzuki M, Endo S, Inada K, et al. Inflammatory cytokines locally elevated in chronic subdural haematoma. Acta Neurochir (Wien). 1998;51–55
  18. Suzuki M, Kudo A, Kitakami A, et al. Local hypercoagulative activity precedes hyperfibrinolytic activity in the subdural space during development of chronic subdural haematoma from subdural effusion. Acta Neurochir (Wien). 1998;140:261–266
  19. Suzuki K, Takano S, Nose T, et al. Increased concentration of vascular endothelial growth factor (VEGF) in chronic subdural hematoma. J Trauma. 1999;46:532–533
  20. Vaquero J, Zurita M, Cincu R. Vascular endothelial growth-permeability factor in granulation tissue of chronic subdural haematomas. Acta Neurochir (Wien). 2002;144:343–347
  21. Weigel R, Hohenstein A, Schlickum L, et al. Angiotensin converting enzyme inhibition for arterial hypertension reduces the risk of recurrence in patients with chronic subdural hematoma possibly by an antiangiogenic mechanism. Neurosurgery. 2007;61:788–793
  22. Weigel R, Schilling L, Schmiedek P. Specific pattern of growth factor distribution in chronic subdural hematoma (CSH): evidence for an angiogenic disease. Acta Neurochir (Wien). 2001;143:811–819
  23. Yamamoto H, Hirashima Y, Hamada H, et al. Independent predictors of recurrence of chronic subdural hematoma: results of multivariate analysis performed using a logistic regression model. J Neurosurg. 2003;98:1217–1221

PII: S0090-3019(08)00043-8

doi: 10.1016/j.surneu.2008.01.023

Surgical Neurology
Volume 71, Issue 2 , Pages 161-165 , February 2009

Article Tools